NEI Ocular Hypertension Treatment Study (OHTS)

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

R. Fechtner, Nicholas Karunaratne, Albert S. Khoury, et al.. (2002). Archives of ophthalmology. Cited 3,821 times. https://doi.org/10.1001/ARCHOPHT.120.6.701

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

M. Gordon, J. Beiser, J. Brandt, et al.. (2002). Archives of ophthalmology. Cited 2,752 times. https://doi.org/10.1097/00132578-200301000-00007

The Ocular Hypertension Treatment Study: design and baseline description of the participants.

M. Gordon, M. Kass. (1999). Archives of ophthalmology. Cited 469 times. https://doi.org/10.1001/ARCHOPHT.117.5.573

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

M. Gordon, V. Torri, S. Miglior, et al.. (2007). Ophthalmology. Cited 340 times. https://doi.org/10.1016/J.OPHTHA.2006.08.031

Classification of visual field abnormalities in the ocular hypertension treatment study.

J. Keltner, Chris A. Johnson, K. E. Cello, et al.. (2000). Archives of ophthalmology. Cited 301 times. https://doi.org/10.1001/ARCHOPHT.121.5.643

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.

D. Budenz, D. Anderson, W. Feuer, et al.. (2006). Ophthalmology. Cited 274 times. https://doi.org/10.1016/J.OPHTHA.2006.06.022

Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.

J. Keltner, Chris A. Johnson, Jacqueline M. Quigg, et al.. (2000). Archives of ophthalmology. Cited 203 times. https://doi.org/10.1001/ARCHOPHT.118.9.1187

Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.

L. Zangwill, R. Weinreb, J. Beiser, et al.. (2005). Archives of ophthalmology. Cited 184 times. https://doi.org/10.1001/ARCHOPHT.123.9.1188

Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.

J. Brandt, J. Beiser, M. Gordon, et al.. (2004). American journal of ophthalmology. Cited 128 times. https://doi.org/10.1016/J.AJO.2004.07.036

Racial differences in optic disc topography: baseline results from the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.

L. Zangwill, R. Weinreb, C. Berry, et al.. (2004). Archives of ophthalmology. Cited 121 times. https://doi.org/10.1001/ARCHOPHT.122.1.22

Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).

James D. Brandt, J. Beiser, Michael A. Kass, et al.. (2001). Ophthalmology. Cited 116 times. https://doi.org/10.1016/S0161-6420(01)00760-6

The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.

J. Keltner, Chris A. Johnson, D. Anderson, et al.. (2006). Ophthalmology. Cited 116 times. https://doi.org/10.1016/J.OPHTHA.2006.05.061

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.

S. Kymes, M. Kass, D. Anderson, et al.. (2006). American journal of ophthalmology. Cited 102 times. https://doi.org/10.1016/J.AJO.2006.01.019

Baseline visual field characteristics in the ocular hypertension treatment study.

Chris A. Johnson, J. Keltner, K. E. Cello, et al.. (2002). Ophthalmology. Cited 94 times. https://doi.org/10.1016/S0161-6420(01)00948-4

Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study.

Jody R. Piltz, Ronald L. Gross, Dong H. Shin, et al.. (2000). American journal of ophthalmology. Cited 90 times. https://doi.org/10.1016/S0002-9394(00)00527-4

The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.

E. Higginbotham, M. Gordon, J. Beiser, et al.. (2004). Archives of ophthalmology. Cited 80 times. https://doi.org/10.1097/01.IEB.0000150396.83885.AC

Changes in central corneal thickness over time: the ocular hypertension treatment study.

J. Brandt, M. Gordon, J. Beiser, et al.. (2008). Ophthalmology. Cited 77 times. https://doi.org/10.1016/j.ophtha.2008.02.001

The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center.

W. Feuer, R. Parrish, J. Schiffman, et al.. (2002). American journal of ophthalmology. Cited 71 times. https://doi.org/10.1016/S0002-9394(01)01338-1

Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study.

A. Bhorade, M. Gordon, Bradley S. Wilson, et al.. (2009). Ophthalmology. Cited 62 times. https://doi.org/10.1016/j.ophtha.2008.12.036

The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors.

L. Zangwill, R. Weinreb, C. Berry, et al.. (2004). American journal of ophthalmology. Cited 58 times. https://doi.org/10.1016/J.AJO.2003.08.031

Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.

R. Levine, S. Demirel, Juanjuan Fan, et al.. (2006). Investigative ophthalmology & visual science. Cited 52 times. https://doi.org/10.1167/IOVS.05-0469

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS)

J. Keltner, Chris A. Johnson, K. E. Cello, et al.. (2005). Journal of Glaucoma. Cited 50 times. https://doi.org/10.1097/IJG.0b013e318057526d

Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

J. Keltner, Chris A. Johnson, R. Levine, et al.. (2005). Archives of ophthalmology. Cited 49 times. https://doi.org/10.1001/ARCHOPHT.123.9.1201

Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.

R. Parrish, J. Schiffman, W. Feuer, et al.. (2005). American journal of ophthalmology. Cited 46 times. https://doi.org/10.1016/J.AJO.2005.04.044

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.

D. Herman, M. Gordon, J. Beiser, et al.. (2006). American journal of ophthalmology. Cited 46 times. https://doi.org/10.1016/J.AJO.2006.06.052

The incidence of retinal vein occlusion in the ocular hypertension treatment study.

E. Barnett, A. Fantín, Bradley S. Wilson, et al.. (2010). Ophthalmology. Cited 46 times. https://doi.org/10.1016/j.ophtha.2009.08.022

Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.

A. Coleman, M. Gordon, J. Beiser, et al.. (2004). American journal of ophthalmology. Cited 42 times. https://doi.org/10.1016/J.AJO.2004.05.030

Is a history of diabetes mellitus protective against developing primary open-angle glaucoma?

M. Gordon, J. Beiser, M. Kass. (2008). Archives of ophthalmology. Cited 30 times. https://doi.org/10.1001/archophthalmol.2007.35

Comparison of initial intraocular pressure response with topical beta-adrenergic antagonists and prostaglandin analogues in African American and white individuals in the Ocular Hypertension Treatment Study.

S. Mansberger, B. Hughes, M. Gordon, et al.. (2007). Archives of ophthalmology. Cited 15 times. https://doi.org/10.1001/ARCHOPHT.125.4.454

Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice.

M. Kass, M. Gordon, S. Kymes. (2005). Archives of ophthalmology. Cited 10 times. https://doi.org/10.1001/ARCHOPHT.123.7.1021-B

Diabetes and glaucoma.

M. Kass, M. Gordon. (2008). Archives of ophthalmology. Cited 2 times. https://doi.org/10.1001/archopht.126.5.746-b